Literature DB >> 22456610

The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor.

Cheng-Han Lee1, Adrian Mariño-Enriquez, Wenbin Ou, Meijun Zhu, Rola H Ali, Sarah Chiang, Frédéric Amant, C Blake Gilks, Matt van de Rijn, Esther Oliva, Maria Debiec-Rychter, Paola Dal Cin, Jonathan A Fletcher, Marisa R Nucci.   

Abstract

Endometrial stromal sarcoma (ESS) is a genetically heterogenous group of uterine sarcomas, of which almost half are associated with JAZF1 rearrangement. We recently identified a novel genetic fusion between YWHAE and FAM22A/B in ESS harboring t(10;17)(q22;p13) and herein describe the clinicopathologic features of 13 YWHAE-FAM22 ESS cases (11 primary and 3 metastatic) and compare them with 20 ESS cases with JAZF1 rearrangement. Ten of 11 primary uterine tumors contained morphologically high-grade areas composed of round cells arranged in nests with a delicate stromal capillary network. The tumor cells showed large nuclei with irregular nuclear contours and significant mitotic activity (>10 mitoses/10 HPF) in addition to focal tumor necrosis, in contrast to JAZF1 ESS, which lacked a nested growth pattern, were composed of cells with small round/oval nuclei, and typically had <5 MF/10 HPF. In 7 of the 11 uterine tumors, there was an additional cytologically bland and mitotically weakly active spindle cell component with a fibrous/fibromyxoid stroma (ESS, fibromyxoid variant). Two metastatic tumors (pulmonary) also contained round cell and spindle cell components, whereas 1 metastasis (vaginal) was composed solely of the spindle cell component. In both primary and metastatic tumors, the spindle cells were diffusely positive for estrogen and progesterone receptors and CD10, in contrast to the round cell areas, which were negative. Clinically, 10 of 12 patients with YWHAE-FAM22 ESS presented with FIGO stages II to III disease, in contrast to only 4 of 16 patients with JAZF1 ESS presenting with stages II to III disease (P<0.05). Tumors with YWHAE-FAM22 rearrangements constitute a distinct group of ESS, which is associated with high-grade morphology and aggressive clinical behavior compared to JAZF1 ESS. Thus, their distinction from typical JAZF1 ESS is important for prognostic and therapeutic purposes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22456610     DOI: 10.1097/PAS.0b013e31824a7b1a

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  53 in total

1.  Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma.

Authors:  Lien N Hoang; Amandeep Aneja; Niamh Conlon; Deborah F Delair; Sumit Middha; Ryma Benayed; Martee L Hensley; Kay J Park; Travis J Hollmann; Meera R Hameed; Cristina R Antonescu; Robert A Soslow; Sarah Chiang
Journal:  Am J Surg Pathol       Date:  2017-01       Impact factor: 6.394

Review 2.  [New features in the 2014 WHO classification of uterine neoplasms].

Authors:  S F Lax
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

Review 3.  High-grade undifferentiated sarcomas of the uterus: diagnosis, outcomes, and new treatment approaches.

Authors:  Charles-André Philip; Patricia Pautier; Florence Duffaud; Isabelle Ray-Coquard
Journal:  Curr Oncol Rep       Date:  2014-10       Impact factor: 5.075

4.  BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology.

Authors:  Sarah Chiang; Cheng-Han Lee; Colin J R Stewart; Esther Oliva; Lien N Hoang; Rola H Ali; Martee L Hensley; Javier A Arias-Stella; Denise Frosina; Achim A Jungbluth; Ryma Benayed; Marc Ladanyi; Meera Hameed; Lu Wang; Yu-Chien Kao; Cristina R Antonescu; Robert A Soslow
Journal:  Mod Pathol       Date:  2017-06-16       Impact factor: 7.842

Review 5.  Practical issues in uterine pathology from banal to bewildering: the remarkable spectrum of smooth muscle neoplasia.

Authors:  Esther Oliva
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

Review 6.  Practical issues related to uterine pathology: endometrial stromal tumors.

Authors:  Marisa R Nucci
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

Review 7.  [Mesenchymal and mixed uterine tumors : Current overview and practical aspects].

Authors:  S F Lax
Journal:  Pathologe       Date:  2019-02       Impact factor: 1.011

8.  Endometrial stromal sarcoma of the uterus presenting as pulmonary metastasis.

Authors:  Fariba Binesh; Shokouh Taghipour Zahir; Ali Akhavan; Taghi Roshan Bovanlu
Journal:  BMJ Case Rep       Date:  2013-08-01

9.  Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement.

Authors:  Cheng-Han Lee; Rola H Ali; Marjan Rouzbahman; Adrian Marino-Enriquez; Meijun Zhu; Xiangqian Guo; Alayne L Brunner; Sarah Chiang; Samuel Leung; Nataliya Nelnyk; David G Huntsman; C Blake Gilks; Torsten O Nielsen; Paola Dal Cin; Matt van de Rijn; Esther Oliva; Jonathan A Fletcher; Marisa R Nucci
Journal:  Am J Surg Pathol       Date:  2012-10       Impact factor: 6.394

Review 10.  Molecular pathological analysis of sarcomas using paraffin-embedded tissue: current limitations and future possibilities.

Authors:  Matt van de Rijn; Xiangqian Guo; Robert T Sweeney; Andrew H Beck; Robert B West
Journal:  Histopathology       Date:  2013-11-25       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.